Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Earnings entities : Sanofi save search
DarioHealth Reports Fourth Quarter and Full-Year 2023 Financial and Operating Results
Published: 2024-03-28 (Crawled : 12:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: -1.17%
H: 0.0%
C: -0.89%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -0.96%
H: 0.0%
C: 0.0%
DRIO | $1.17 1.74% 1.71% 50K
|
Health Technology
|
| O: -4.61%
H: 14.48%
C: 5.52%
financial results
Sangamo Therapeutics Reports Recent Business Highlights and Fourth Quarter and Full Year 2023 Financial Results
Published: 2024-03-13 (Crawled : 13:00) - biospace.com/
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -0.04%
H: 0.0%
C: 0.0%
SGMO | $0.5143 6.02% 5.68% 1M
|
Health Technology
|
| O: 2.19%
H: 4.55%
C: -10.78%
business year therapeutics financial results
COVID-19 Cliff and Skyrocketing GLP-1 Drug Sales Highlight Q4 2023 Earnings
Published: 2024-02-09 (Crawled : 17:00) - biospace.com/
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: -0.68%
H: 0.0%
C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 1.11%
H: 0.0%
C: 0.0%
covid-19 sales drug
AstraZeneca Full year and Q4 2023 Financial Results
Published: 2024-02-08 (Crawled : 09:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: -1.64%
H: 0.0%
C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -2.25%
H: 0.0%
C: 0.0%
year astrazeneca financial results
GSK Sees Sales Uptick in 2023 Fueled by Vaccines for RSV and Shingles
Published: 2024-02-02 (Crawled : 17:00) - biospace.com/
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -0.93%
H: 0.0%
C: 0.0%
sales rsv
Merck Announces Fourth-Quarter and Full-Year 2023 Financial Results
Published: 2024-02-01 (Crawled : 23:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: -4.37%
H: 0.0%
C: 0.0%
MRK | News | $125.78 0.44% 0.0% 8.4M
|
Health Technology
|
| O: 2.38%
H: 2.25%
C: 2.21%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -5.26%
H: 0.0%
C: 0.0%
MRNA S | $101.44 -0.55% -0.55% 2.6M
|
Health Technology
|
| O: -0.15%
H: 0.1%
C: -1.86%
HARP | $23.01 0.07% 6.6M
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: 0.0%
merck financial results
Sanofi Hit with $600M Net Loss in Q4 Amid Generic Competition
Published: 2024-02-01 (Crawled : 14:30) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: -4.37%
H: 0.0%
C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -5.26%
H: 0.0%
C: 0.0%
sanofi
Adimab Provides Year-End Update on 2023 Partnership Activities
Published: 2024-01-08 (Crawled : 16:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: 2.07%
H: 0.48%
C: 0.48%
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: 0.47%
H: 0.0%
C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 1.16%
H: 0.0%
C: 0.0%
partnership update
Innate Pharma Reports Third Quarter 2023 Financial Results and Business Update
Published: 2023-11-14 (Crawled : 09:00) - biospace.com/
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.68%
H: 0.0%
C: 0.0%
IPHA | $2.48 5.53% 5.24% 9.4K
|
Health Technology
|
| O: 6.61%
H: 9.39%
C: 6.61%
pharma business update financial results
Teva Reports Third Quarter 2023 Financial Results and Increases Revenue Guidance
Published: 2023-11-08 (Crawled : 14:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: -0.33%
H: 0.0%
C: 0.0%
TEVA | $12.86 0.63% 0.0% 10M
|
Health Technology
|
| O: 2.54%
H: 3.23%
C: -1.29%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 1.62%
H: 0.0%
C: 0.0%
revenue teva financial results
Innate Pharma Announces Conference Call for Third Quarter 2023 Business Update
Published: 2023-11-07 (Crawled : 08:00) - biospace.com/
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -1.32%
H: 0.0%
C: 0.0%
IPHA | $2.48 5.53% 5.24% 9.4K
|
Health Technology
|
| O: -2.31%
H: 2.76%
C: 1.18%
pharma conference business update
MacroGenics Provides Update on Corporate Progress and Third Quarter 2023 Financial Results
Published: 2023-11-06 (Crawled : 00:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: 0.16%
H: 0.0%
C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.21%
H: 0.0%
C: 0.0%
MGNX | $15.62 -2.8% -2.88% 1M
|
Health Technology
|
| O: 1.69%
H: 2.96%
C: 0.74%
GILD | $66.77 0.92% 0.91% 11M
|
Health Technology
|
| O: 0.1%
H: 0.38%
C: -0.65%
update financial results
Alnylam Pharmaceuticals Reports Third Quarter 2023 Financial Results and Highlights Recent Period Activity
Published: 2023-11-02 (Crawled : 13:00) - biospace.com/
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 3.0%
H: 0.0%
C: 0.0%
ALNY | $144.315 -0.58% -0.59% 700K
|
Health Technology
|
| O: 3.4%
H: 0.57%
C: -0.5%
pharmaceuticals financial results
Innate Pharma 2024 Financial Calendar
Published: 2023-10-19 (Crawled : 07:00) - biospace.com/
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -2.42%
H: 0.0%
C: 0.0%
IPHA | $2.48 5.53% 5.24% 9.4K
|
Health Technology
|
| O: -8.78%
H: 15.06%
C: 0.0%
pharma financial
DarioHealth Reports Second Quarter 2023 Financial and Operating Results
Published: 2023-08-10 (Crawled : 12:00) - biospace.com/
AMWL | $0.5466 5.54% -0.22% 2.1M
|
Technology Services
|
| O: 1.14%
H: 0.0%
C: -5.65%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 1.52%
H: 1.05%
C: 0.47%
DRIO | $1.17 1.74% 1.71% 50K
|
Health Technology
|
| O: -0.87%
H: 3.81%
C: -7.62%
financial results
Week in Review: Breakthrough Depression Drug, RSV and GLP-1 Lawsuits, and Earnings Season Shows C...
Published: 2023-08-04 (Crawled : 21:00) - biospace.com/
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 2.43%
H: 0.0%
C: 0.0%
depression rsv week
Regeneron Eyes Earlier FDA Decision on Higher-Dose Eylea
Published: 2023-08-03 (Crawled : 17:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: -1.6%
H: 0.11%
C: 0.11%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -3.79%
H: 0.0%
C: 0.0%
fda eylea
Alnylam Pharmaceuticals Reports Second Quarter 2023 Financial Results and Highlights Recent Period Activity
Published: 2023-08-03 (Crawled : 13:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: -1.6%
H: 0.11%
C: 0.11%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -3.79%
H: 0.0%
C: 0.0%
ALNY | $144.315 -0.58% -0.59% 700K
|
Health Technology
|
| O: -1.35%
H: 5.58%
C: 4.38%
pharmaceuticals financial results
Seagen Second Quarter 2023 Financial Results Demonstrate Exceptional Commercial Performance Driving Record Product Sales with Strong Growth and Momentum
Published: 2023-08-02 (Crawled : 13:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: -2.23%
H: 0.0%
C: -0.56%
SGEN | $228.74 0.1% 20M
|
Health Technology
|
| O: 0.08%
H: 0.43%
C: 0.2%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -2.64%
H: 0.0%
C: 0.0%
sales momentum commercial financial results growth
Innate Pharma Reports First Quarter 2023 Financial Results and Business Update
Published: 2023-05-10 (Crawled : 09:00) - biospace.com/
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -1.75%
H: 0.0%
C: 0.0%
IPHA | $2.48 5.53% 5.24% 9.4K
|
Health Technology
|
| O: -2.46%
H: 2.18%
C: -1.34%
pharma business update financial results
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.